Zubair AC - Search Results

1

Low baseline platelet count predicts poor response to plerixafor in patients with multiple myeloma undergoing autologous stem cell mobilization.

Bakeer M, Zubair AC, Roy V. Bakeer M, et al. Among authors: zubair ac. Cytotherapy. 2020 Jan;22(1):16-20. doi: 10.1016/j.jcyt.2019.10.008. Epub 2019 Dec 24. Cytotherapy. 2020. PMID: 31879152

2

CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.

Zubair AC, Kao G, Daley H, Schott D, Freedman A, Ritz J. Zubair AC, et al. Cytotherapy. 2006;8(4):399-407. doi: 10.1080/14653240600847241. Cytotherapy. 2006. PMID: 16923616

3

Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients.

Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Zubair AC, et al. Transfusion. 2008 Jun;48(6):1106-14. doi: 10.1111/j.1537-2995.2008.01651.x. Epub 2008 Feb 25. Transfusion. 2008. PMID: 18315528 Free PMC article.

4

Multiple myeloma patients receiving large volume leukapheresis efficiently yield enough CD34+ cells to allow double transplants.

Zubair AC, Rymer R, Young J, Keeton U, Befort R, Nolot B, Evans C, Bleach T, Torloni A. Zubair AC, et al. J Clin Apher. 2009;24(1):6-11. doi: 10.1002/jca.20190. J Clin Apher. 2009. PMID: 19156756 Free PMC article.

5

Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cells.

Zubair AC, Malik S, Paulsen A, Ishikawa M, McCoy C, Adams PX, Amrani D, Costa M. Zubair AC, et al. Cytotherapy. 2010 Apr;12(2):178-89. doi: 10.3109/14653240903493409. Cytotherapy. 2010. PMID: 20078384 Free PMC article.

6

Efficacy and cost-benefit analysis of risk-adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization.

Vishnu P, Roy V, Paulsen A, Zubair AC. Vishnu P, et al. Among authors: zubair ac. Transfusion. 2012 Jan;52(1):55-62. doi: 10.1111/j.1537-2995.2011.03206.x. Epub 2011 Jun 9. Transfusion. 2012. PMID: 21658047

7

Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent.

Jiang L, Malik S, Litzow M, Gastineau D, Micallef I, Roy V, Solberg L, Zubair AC. Jiang L, et al. Among authors: zubair ac. Transfusion. 2012 Mar;52(3):542-8. doi: 10.1111/j.1537-2995.2011.03286.x. Epub 2011 Aug 9. Transfusion. 2012. PMID: 21827503 Free PMC article. Clinical Trial.

8

Mechanism of mesenchymal stem cell-induced neuron recovery and anti-inflammation.

Huang P, Gebhart N, Richelson E, Brott TG, Meschia JF, Zubair AC. Huang P, et al. Among authors: zubair ac. Cytotherapy. 2014 Oct;16(10):1336-44. doi: 10.1016/j.jcyt.2014.05.007. Epub 2014 Jun 11. Cytotherapy. 2014. PMID: 24927715

9

Dual roles of autologous CD8+ T cells in hematopoietic progenitor cell mobilization and engraftment.

Russell A, Malik S, Litzow M, Gastineau D, Roy V, Zubair AC. Russell A, et al. Among authors: zubair ac. Transfusion. 2015 Jul;55(7):1758-65; quiz 1757. doi: 10.1111/trf.13073. Epub 2015 Mar 11. Transfusion. 2015. PMID: 25757596

10

Genetic modification of H2AX renders mesenchymal stromal cell-derived dopamine neurons more resistant to DNA damage and subsequent apoptosis.

Jiang P, Huang P, Yen SH, Zubair AC, Dickson DW. Jiang P, et al. Among authors: zubair ac. Cytotherapy. 2016 Dec;18(12):1483-1492. doi: 10.1016/j.jcyt.2016.08.008. Epub 2016 Oct 6. Cytotherapy. 2016. PMID: 27720638 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters